• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在 MVD 或 MVK 突变杂合子中,具有体细胞重组或 C>T 转换的二次打击细胞的克隆扩增形成汗孔角化病。

Clonal Expansion of Second-Hit Cells with Somatic Recombinations or C>T Transitions Form Porokeratosis in MVD or MVK Mutant Heterozygotes.

机构信息

Department of Dermatology, Keio University School of Medicine, Tokyo, Japan; Keio-Maruho Laboratory of Skin Barriology, Keio University School of Medicine, Tokyo, Japan.

Center for Supercentenarian Medical Research, Keio University School of Medicine, Tokyo, Japan.

出版信息

J Invest Dermatol. 2019 Dec;139(12):2458-2466.e9. doi: 10.1016/j.jid.2019.05.020. Epub 2019 Jun 15.

DOI:10.1016/j.jid.2019.05.020
PMID:31207227
Abstract

Patients with disseminated superficial actinic porokeratosis (DSAP) and linear porokeratosis (LP) exhibit monoallelic germline mutations in genes encoding mevalonate pathway enzymes, such as MVD or MVK. Here, we showed that each skin lesion of DSAP exhibited an individual second hit genetic change in the wild-type allele of the corresponding gene specifically in the epidermis, indicating that a postnatal second hit triggering biallelic deficiency of the gene is required for porokeratosis to develop. Most skin lesions exhibited one of two principal second hits, either somatic homologous recombinations rendering the monoallelic mutation biallelic or C>T transition mutations in the wild-type allele. The second hits differed among DSAP lesions but were identical in those of congenital LP, suggesting that DSAP is attributable to sporadic postnatal second hits and congenital LP to a single second hit in the embryonic period. In the characteristic annular skin lesions of DSAP, the central epidermis featured mostly second hit keratinocytes, and that of the annular ring featured a mixture of such cells and naïve keratinocytes, implying that each lesion reflects the clonal expansion of single second hit keratinocytes. DSAP is therefore a benign intraepidermal neoplasia, which can be included in the genetic tumor disorders explicable by Knudson's two-hit hypothesis.

摘要

患有播散性浅表光化性汗孔角化症(DSAP)和线状汗孔角化症(LP)的患者表现出编码甲羟戊酸途径酶(如 MVD 或 MVK)的基因的单等位基因种系突变。在这里,我们表明 DSAP 的每个皮肤病变在对应基因的野生型等位基因中表现出特定于表皮的个体二次打击遗传变化,表明需要出生后的二次打击触发基因的双等位基因缺陷才能发展为汗孔角化症。大多数皮肤病变表现出两种主要二次打击中的一种,要么是导致单等位基因突变双等位基因的体细胞同源重组,要么是野生型等位基因中的 C>T 转换突变。二次打击在 DSAP 病变之间存在差异,但在先天性 LP 的病变中是相同的,表明 DSAP 归因于散发性出生后二次打击,先天性 LP 归因于胚胎期的单次二次打击。在 DSAP 的特征性环形皮肤病变中,中央表皮主要是二次打击角质形成细胞,而环形环的表皮则是这些细胞和幼稚角质形成细胞的混合物,这意味着每个病变反映了单个二次打击角质形成细胞的克隆扩张。因此,DSAP 是一种良性表皮内肿瘤,可以包括在可通过 Knudson 的两次打击假说解释的遗传肿瘤疾病中。

相似文献

1
Clonal Expansion of Second-Hit Cells with Somatic Recombinations or C>T Transitions Form Porokeratosis in MVD or MVK Mutant Heterozygotes.在 MVD 或 MVK 突变杂合子中,具有体细胞重组或 C>T 转换的二次打击细胞的克隆扩增形成汗孔角化病。
J Invest Dermatol. 2019 Dec;139(12):2458-2466.e9. doi: 10.1016/j.jid.2019.05.020. Epub 2019 Jun 15.
2
Novel mutations in mevalonate kinase cause disseminated superficial actinic porokeratosis.新型戊二酰基辅酶 A 激酶突变导致播散性浅表光化性汗孔角化症。
Br J Dermatol. 2019 Aug;181(2):304-313. doi: 10.1111/bjd.17596. Epub 2019 Mar 18.
3
Detection of a novel missense mutation in the mevalonate kinase gene in one Chinese family with DSAP.在中国一个伴弥漫性掌跖角皮症(DSAP)的家族中检测到甲羟戊酸激酶基因的一种新型错义突变。
Int J Clin Exp Pathol. 2014 Jan 15;7(2):728-32. eCollection 2014.
4
Exome sequencing identifies MVK mutations in disseminated superficial actinic porokeratosis.外显子组测序鉴定出播散性浅表光化性汗孔角化症中的 MVK 突变。
Nat Genet. 2012 Oct;44(10):1156-60. doi: 10.1038/ng.2409. Epub 2012 Sep 16.
5
Identification of three mutations in the MVK gene in six patients associated with disseminated superficial actinic porokeratosis.在6例与播散性浅表光化性汗孔角化症相关的患者中鉴定出MVK基因的三种突变。
Clin Chim Acta. 2016 Feb 15;454:124-9. doi: 10.1016/j.cca.2016.01.009. Epub 2016 Jan 12.
6
Splicing mutation in MVK is a cause of porokeratosis of Mibelli.甲羟戊酸激酶(MVK)的剪接突变是米贝利汗孔角化症的病因之一。
Arch Dermatol Res. 2014 Oct;306(8):749-55. doi: 10.1007/s00403-014-1465-7. Epub 2014 Apr 30.
7
Novel missense mutations of MVK and FDPS gene in Chinese patients with disseminated superficial actinic porokeratosis.中国播散性浅表光线性汗孔角化症患者 MVK 和 FDPS 基因的新型错义突变。
Clin Chim Acta. 2021 Dec;523:441-445. doi: 10.1016/j.cca.2021.10.026. Epub 2021 Oct 28.
8
Characterization of the ultraviolet B and X-ray response of primary cultured epidermal cells from patients with disseminated superficial actinic porokeratosis.播散性浅表性光化性汗孔角化症患者原代表皮细胞的紫外线B和X射线反应特征
Br J Dermatol. 2004 Jan;150(1):47-55. doi: 10.1111/j.1365-2133.2004.05714.x.
9
Mutation analysis of the MVK gene in Chinese patients with disseminated superficial actinic porokeratosis.中国播散性浅表性光化性汗孔角化症患者MVK基因的突变分析
J Dermatol Sci. 2013 Dec;72(3):320-2. doi: 10.1016/j.jdermsci.2013.07.011. Epub 2013 Aug 8.
10
Second-Hit Somatic Mutations in Mevalonate Pathway Genes Underlie Porokeratosis.Mevalonate 途径基因中的二次打击体细胞突变是导致角化病的原因。
J Invest Dermatol. 2019 Dec;139(12):2409-2411. doi: 10.1016/j.jid.2019.07.723.

引用本文的文献

1
A Patient With Concurrent Hidradenitis Suppurativa and Porokeratosis Palmaris et Plantaris Disseminata: Case Report and Review of Autoinflammatory Keratinization Diseases.一名同时患有化脓性汗腺炎和播散性掌跖汗孔角化症的患者:病例报告及自身炎症性角化病综述
J Cutan Pathol. 2025 Apr;52(4):272-277. doi: 10.1111/cup.14774. Epub 2025 Jan 3.
2
Advanced phasing techniques in congenital skin diseases.先天性皮肤病的先进分型技术
J Dermatol. 2025 Mar;52(3):392-399. doi: 10.1111/1346-8138.17597. Epub 2024 Dec 26.
3
Mevalonate kinase deficiency: an updated clinical overview and revision of the SHARE recommendations.
甲羟戊酸激酶缺乏症:临床最新综述及 SHARE 建议修订版。
Front Immunol. 2024 Nov 12;15:1466844. doi: 10.3389/fimmu.2024.1466844. eCollection 2024.
4
Somatic mutations in autoinflammatory and autoimmune disease.自身炎症性和自身免疫性疾病中的体细胞突变。
Nat Rev Rheumatol. 2024 Nov;20(11):683-698. doi: 10.1038/s41584-024-01168-8. Epub 2024 Oct 11.
5
Malignant Transformation in Porokeratosis Ptychotropica: A Systematic Review.棘层松解性角化不良瘤样恶变:系统回顾。
Acta Derm Venereol. 2024 Oct 10;104:adv40558. doi: 10.2340/actadv.v104.40558.
6
Epidermal second-hit mutation in gene associated with linear porokeratosis.与线状汗孔角化症相关基因中的表皮二次打击突变。
Genes Dis. 2024 Apr 29;12(1):101314. doi: 10.1016/j.gendis.2024.101314. eCollection 2025 Jan.
7
Establishment of a Mouse Model for Porokeratosis Due to Mevalonate Diphosphate Decarboxylase Deficiency.建立 Mevalonate Diphosphate Decarboxylase 缺陷导致的掌跖角化病小鼠模型。
Skin Res Technol. 2024 Sep;30(9):e70076. doi: 10.1111/srt.70076.
8
Gene-specific somatic epigenetic mosaicism of FDFT1 underlies a non-hereditary localized form of porokeratosis.FDFT1基因特异性体细胞表观遗传镶嵌现象是局限性汗孔角化症非遗传性局部型的基础。
Am J Hum Genet. 2024 May 2;111(5):896-912. doi: 10.1016/j.ajhg.2024.03.017. Epub 2024 Apr 22.
9
Genetically transitional disease: conceptual understanding and applicability to rheumatic disease.遗传过渡性疾病:概念理解及其在风湿性疾病中的适用性。
Nat Rev Rheumatol. 2024 May;20(5):301-310. doi: 10.1038/s41584-024-01086-9. Epub 2024 Feb 28.
10
Clinical Challenges of Emerging Acquired Autoinflammatory Diseases, Including VEXAS Syndrome.包括VEXAS综合征在内的新发获得性自身炎症性疾病的临床挑战
Intern Med. 2025 Jan 1;64(1):25-30. doi: 10.2169/internalmedicine.3219-23. Epub 2024 Feb 1.